References

Spatial transcriptomics: Technical aspects of recent developments and their applications in neuroscience and cancer research

10.1002/advs.202206939 · ExternalCitation · doi-reference

The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma

10.1002/ctm2.1074 · ExternalCitation · doi-reference

Tertiary lymphoid structures in cancer: Immune mechanisms and clinical implications

10.1002/mco2.489 · ExternalCitation · doi-reference

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection

10.1007/s00109-014-1189-3 · ExternalCitation · doi-reference

High endothelial venules (HEVs) in immunity, inflammation and cancer

10.1007/s10456-021-09792-8 · ExternalCitation · doi-reference

Metabolic dialogs between B cells and the tumor microenvironment: Implications for anticancer immunity

10.1016/j.canlet.2023.216076 · ExternalCitation · doi-reference

Critical role for CD103(+)/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma

10.1016/j.ccell.2016.06.003 · ExternalCitation · doi-reference

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

10.1016/j.ccell.2021.02.013 · ExternalCitation · doi-reference

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

10.1016/j.ccell.2021.03.007 · ExternalCitation · doi-reference

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

10.1016/j.ccell.2022.01.002 · ExternalCitation · doi-reference

Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop

10.1016/j.ccell.2022.12.006 · ExternalCitation · doi-reference

High endothelial venules in cancer: regulation, function, and therapeutic implication

10.1016/j.ccell.2023.02.002 · ExternalCitation · doi-reference

CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis

10.1016/j.ccell.2024.07.006 · ExternalCitation · doi-reference

Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures

10.1016/j.ccell.2025.03.011 · ExternalCitation · doi-reference

B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity

10.1016/j.ccell.2025.12.011 · ExternalCitation · doi-reference

A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging

10.1016/j.cell.2018.08.039 · ExternalCitation · doi-reference

Defining T cell states associated with response to checkpoint immunotherapy in melanoma

10.1016/j.cell.2018.12.034 · ExternalCitation · doi-reference

Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front

10.1016/j.cell.2020.07.005 · ExternalCitation · doi-reference

Spatially organized multicellular immune hubs in human colorectal cancer

10.1016/j.cell.2021.08.003 · ExternalCitation · doi-reference

Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies

10.1016/j.celrep.2019.04.091 · ExternalCitation · doi-reference

Integrated spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structures

10.1016/j.celrep.2025.116250 · ExternalCitation · doi-reference

Tumor microenvironmental nutrients, cellular responses, and cancer

10.1016/j.chembiol.2023.08.011 · ExternalCitation · doi-reference

LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells

10.1016/j.cmet.2016.08.011 · ExternalCitation · doi-reference

CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability

10.1016/j.cmet.2021.02.015 · ExternalCitation · doi-reference

Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy

10.1016/j.cmet.2023.06.003 · ExternalCitation · doi-reference

Lactate in the tumour microenvironment: From immune modulation to therapy

10.1016/j.ebiom.2021.103627 · ExternalCitation · doi-reference

Oncology meets immunology: the cancer-immunity cycle

10.1016/j.immuni.2013.07.012 · ExternalCitation · doi-reference

Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses

10.1016/j.immuni.2015.08.006 · ExternalCitation · doi-reference

Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms

10.1016/j.immuni.2020.04.014 · ExternalCitation · doi-reference

Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors

10.1016/j.immuni.2021.05.003 · ExternalCitation · doi-reference

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer

10.1016/j.immuni.2022.02.001 · ExternalCitation · doi-reference

Tertiary lymphoid structures and B cells: an intratumoral immunity cycle

10.1016/j.immuni.2023.08.009 · ExternalCitation · doi-reference

Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures

10.1016/j.immuni.2025.09.018 · ExternalCitation · doi-reference

Tertiary lymphoid organs in infection and autoimmunity

10.1016/j.it.2012.04.006 · ExternalCitation · doi-reference

Tertiary lymphoid structures in cancer and beyond

10.1016/j.it.2014.09.006 · ExternalCitation · doi-reference

Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

10.1016/j.jhep.2018.09.003 · ExternalCitation · doi-reference

Standardized pathology screening of mature tertiary lymphoid structures in cancers

10.1016/j.labinv.2023.100063 · ExternalCitation · doi-reference

Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside

10.1016/j.medj.2024.10.023 · ExternalCitation · doi-reference

Activation of B cells in tertiary lymphoid structures in cancer: Anti-tumor or anti-self

10.1016/j.smim.2022.101703 · ExternalCitation · doi-reference

The tumor-draining lymph node as a reservoir for systemic immune surveillance

10.1016/j.trecan.2023.09.006 · ExternalCitation · doi-reference

An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure

10.1016/j.xcrm.2024.101448 · ExternalCitation · doi-reference

Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures

10.1016/j.xcrm.2025.101934 · ExternalCitation · doi-reference

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy

10.1038/cmi.2017.13 · ExternalCitation · doi-reference

Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

10.1038/ni.3290 · ExternalCitation · doi-reference

Lipid accumulation and dendritic cell dysfunction in cancer

10.1038/nm.2172 · ExternalCitation · doi-reference

Hypoxia--a key regulatory factor in tumour growth

10.1038/nrc704 · ExternalCitation · doi-reference

Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges

10.1038/nrclinonc.2018.29 · ExternalCitation · doi-reference

Improving immune-vascular crosstalk for cancer immunotherapy

10.1038/nri.2017.145 · ExternalCitation · doi-reference

Lymphoid neogenesis in chronic inflammatory diseases

10.1038/nri1786 · ExternalCitation · doi-reference

HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

10.1038/nri3298 · ExternalCitation · doi-reference

Ectopic lymphoid-like structures in infection, cancer and autoimmunity

10.1038/nri3700 · ExternalCitation · doi-reference

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances

10.1038/s41392-024-01947-5 · ExternalCitation · doi-reference

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

10.1038/s41467-021-23355-x · ExternalCitation · doi-reference

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

10.1038/s41467-022-29040-x · ExternalCitation · doi-reference

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy

10.1038/s41467-022-29753-z · ExternalCitation · doi-reference

Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

10.1038/s41467-024-46873-w · ExternalCitation · doi-reference

Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma

10.1038/s41467-024-52153-4 · ExternalCitation · doi-reference

MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma

10.1038/s41467-025-56392-x · ExternalCitation · doi-reference

Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer

10.1038/s41467-025-59341-w · ExternalCitation · doi-reference

Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer

10.1038/s41467-025-65421-8 · ExternalCitation · doi-reference

Tertiary lymphoid structures in the era of cancer immunotherapy

10.1038/s41568-019-0144-6 · ExternalCitation · doi-reference

Metabolism of immune cells in cancer

10.1038/s41568-020-0273-y · ExternalCitation · doi-reference

Tertiary lymphoid structures in anticancer immunity

10.1038/s41568-024-00728-0 · ExternalCitation · doi-reference

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy

10.1038/s41571-019-0203-7 · ExternalCitation · doi-reference

The adenosine pathway in immuno-oncology

10.1038/s41571-020-0382-2 · ExternalCitation · doi-reference

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

10.1038/s41571-022-00619-z · ExternalCitation · doi-reference

Methods and applications for single-cell and spatial multi-omics

10.1038/s41576-023-00580-2 · ExternalCitation · doi-reference

Metabolic barriers to cancer immunotherapy

10.1038/s41577-021-00541-y · ExternalCitation · doi-reference

The roles of tertiary lymphoid structures in chronic diseases

10.1038/s41581-023-00706-z · ExternalCitation · doi-reference

B cells are associated with survival and immunotherapy response in sarcoma

10.1038/s41586-019-1906-8 · ExternalCitation · doi-reference

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

10.1038/s41586-019-1914-8 · ExternalCitation · doi-reference

B cells and tertiary lymphoid structures promote immunotherapy response

10.1038/s41586-019-1922-8 · ExternalCitation · doi-reference

Cell-programmed nutrient partitioning in the tumour microenvironment

10.1038/s41586-021-03442-1 · ExternalCitation · doi-reference

IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer

10.1038/s41586-024-08426-5 · ExternalCitation · doi-reference

Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade

10.1038/s41590-019-0312-6 · ExternalCitation · doi-reference

Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

10.1038/s41590-024-01792-2 · ExternalCitation · doi-reference

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

10.1038/s41590-024-01992-w · ExternalCitation · doi-reference

Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma

10.1038/s41698-024-00752-1 · ExternalCitation · doi-reference

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

10.1038/s43018-021-00232-6 · ExternalCitation · doi-reference

Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy

10.1053/j.gastro.2023.10.022 · ExternalCitation · doi-reference

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

10.1080/2162402x.2021.1900635 · ExternalCitation · doi-reference

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy

10.1093/annonc/mdx727 · ExternalCitation · doi-reference

CXCL9 and CXCL13 shape endometrial cancer immune-activated microenvironment via tertiary lymphoid structure formation

10.1111/cas.16371 · ExternalCitation · doi-reference

Regulatory B cells in cancer

10.1111/imr.12939 · ExternalCitation · doi-reference

Tertiary lymphoid structures in cancer

10.1126/science.abf9419 · ExternalCitation · doi-reference

Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics

10.1126/science.adf8486 · ExternalCitation · doi-reference

A blueprint for tumor-infiltrating B cells across human cancers

10.1126/science.adj4857 · ExternalCitation · doi-reference

Tumor-draining lymph nodes: at the crossroads of metastasis and immunity

10.1126/sciimmunol.abg3551 · ExternalCitation · doi-reference

A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

10.1126/sciimmunol.adi4191 · ExternalCitation · doi-reference

Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer

10.1136/jitc-2022-005539 · ExternalCitation · doi-reference

Multiplex imaging in immuno-oncology

10.1136/jitc-2023-006923 · ExternalCitation · doi-reference

MCT4 blockade increases the efficacy of immune checkpoint blockade

10.1136/jitc-2023-007349 · ExternalCitation · doi-reference

Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer

10.1136/jitc-2024-009243 · ExternalCitation · doi-reference

Metabolism in the tumor microenvironment

10.1146/annurev-cancerbio-030419-033333 · ExternalCitation · doi-reference

Inhibition of the adenosine pathway to potentiate cancer immunotherapy: Potential for combinatorial approaches

10.1146/annurev-med-060619-023155 · ExternalCitation · doi-reference

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer

10.1158/0008-5472.can-11-0431 · ExternalCitation · doi-reference

Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer

10.1158/0008-5472.can-11-0952 · ExternalCitation · doi-reference

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

10.1158/0008-5472.can-13-1342 · ExternalCitation · doi-reference

Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma

10.1158/0008-5472.can-17-1987 · ExternalCitation · doi-reference

Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer

10.1158/1078-0432.ccr-15-2762 · ExternalCitation · doi-reference

B cells and tertiary lymphoid structures: Friends or foes in cancer immunotherapy

10.1158/1078-0432.ccr-21-1130 · ExternalCitation · doi-reference

Upregulation of indoleamine 2,3-dioxygenase 1 in tumor cells and tertiary lymphoid structures is a hallmark of inflamed non-small cell lung cancer

10.1158/1078-0432.ccr-23-1928 · ExternalCitation · doi-reference

Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma

10.1158/2159-8290.cd-24-0991 · ExternalCitation · doi-reference

CD86(+) antigen-presenting B cells are increased in cancer, localize in tertiary lymphoid structures, and induce specific T-cell responses

10.1158/2326-6066.cir-20-0949 · ExternalCitation · doi-reference

Sensory nerves impede the formation of tertiary lymphoid structures and development of protective antimelanoma immune responses

10.1158/2326-6066.cir-22-0110 · ExternalCitation · doi-reference

Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer

10.1164/rccm.201309-1611oc · ExternalCitation · doi-reference

Fighting in a wasteland: deleterious metabolites and antitumor immunity

10.1172/jci148549 · ExternalCitation · doi-reference

Tumor-derived lactic acid modulates dendritic cell activation and antigen expression

10.1182/blood-2005-05-1795 · ExternalCitation · doi-reference

Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing

10.1186/s12885-023-10977-1 · ExternalCitation · doi-reference

The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy

10.1186/s12916-025-04037-7 · ExternalCitation · doi-reference

Characterizing tertiary lymphoid structures associated single-cell atlas in breast cancer patients

10.1186/s12935-025-03635-y · ExternalCitation · doi-reference

Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application

10.1186/s12943-024-01980-6 · ExternalCitation · doi-reference

Reprogramming of lipid metabolism in the tumor microenvironment: A strategy for tumor immunotherapy

10.1186/s12944-024-02024-0 · ExternalCitation · doi-reference

Hypoxia and the phenomenon of immune exclusion

10.1186/s12967-020-02667-4 · ExternalCitation · doi-reference

Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities​​

10.1186/s13045-025-01754-7 · ExternalCitation · doi-reference

Targeting adenosine for cancer immunotherapy

10.1186/s40425-018-0360-8 · ExternalCitation · doi-reference

Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures

10.1200/jco.2007.15.0284 · ExternalCitation · doi-reference

Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy

10.20892/j.issn.2095-3941.2024.0228 · ExternalCitation · doi-reference

Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts

10.2139/ssrn.3575119 · ExternalCitation · doi-reference

A pan-cancer single-cell RNA-seq atlas of intratumoral B cells

10.2139/ssrn.4663949 · ExternalCitation · doi-reference

Regulatory role of CD39 and CD73 in tumor immunity

10.2217/fon-2023-0871 · ExternalCitation · doi-reference

Accomplices of the hypoxic tumor microenvironment compromising antitumor immunity: Adenosine, lactate, acidosis, vascular endothelial growth factor, potassium ions, and phosphatidylserine

10.3389/fimmu.2017.01887 · ExternalCitation · doi-reference

Targeting hypoxia-A2A adenosinergic immunosuppression of antitumor T cells during cancer immunotherapy

10.3389/fimmu.2020.570041 · ExternalCitation · doi-reference

High endothelial venules: A vascular perspective on tertiary lymphoid structures in cancer

10.3389/fimmu.2021.736670 · ExternalCitation · doi-reference

Adenosine-A2A receptor pathway in cancer immunotherapy

10.3389/fimmu.2022.837230 · ExternalCitation · doi-reference

Heterogeneity of tertiary lymphoid structures in cancer

10.3389/fimmu.2023.1286850 · ExternalCitation · doi-reference

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy

10.3389/fimmu.2024.1353787 · ExternalCitation · doi-reference

Tertiary lymphoid structures: new immunotherapy biomarker

10.3389/fimmu.2024.1394505 · ExternalCitation · doi-reference

Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring

10.3389/fimmu.2024.1422206 · ExternalCitation · doi-reference

Hypoxia-adenosinergic regulation of B cell responses

10.3389/fimmu.2024.1478506 · ExternalCitation · doi-reference

From metabolic byproduct to immune modulator: The role of lactate in tumor immune escape

10.3389/fimmu.2024.1492050 · ExternalCitation · doi-reference

Inhibition of A2AR alleviates adenosine-mediated suppression of plasma cell differentiation

10.3389/fimmu.2025.1702402 · ExternalCitation · doi-reference

Lipid metabolism in tumor immunology and immunotherapy

10.3389/fonc.2023.1187279 · ExternalCitation · doi-reference

Hypoxia-driven immune escape in the tumor microenvironment

10.3390/cells9040992 · ExternalCitation · doi-reference

Lactic acid and an acidic tumor microenvironment suppress anticancer immunity

10.3390/ijms21218363 · ExternalCitation · doi-reference

CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes

10.4049/jimmunol.180.9.6288 · ExternalCitation · doi-reference

Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism

10.4049/jimmunol.212.supp.1394.5643 · ExternalCitation · doi-reference

B cells and tertiary lymphoid structures in tumors: Immunity cycle, clinical impact, and therapeutic applications

10.7150/thno.105423 · ExternalCitation · doi-reference